-transparent.png){kind=logo}
Human skin penetration of N-dimethylnitrosamine (DMN) from three vehicles has been determined in vitro. When applied as an infinite dose in isopropyl myristate (IPM, 1 microgram/microliter) the average total absorption over 48 hr was 2.6 +/- 1.2% of the applied dose (all data presented are expressed as means +/- standard errors). When applied as a finite dose in a representative oil-in-water emulsion vehicle the average total absorption over 48 hr was 4.0 +/- 0.3% of the applied dose. When applied as a finite dose in a representative shampoo vehicle for 10 min followed by rinsing (i.e. to represent in-use exposure conditions) the average total absorption over 48 hr was 1.1 +/- 0.1% of the applied dose. Approximately 72% of the DMN in the applied shampoo vehicle was removed by rinsing. There was considerable evaporative loss of DMN from the IPM and oil-in-water emulsion vehicles, such that absorption was complete within 3 hr of application. The overall data indicate that DMN can penetrate the skin rapidly but that in practice the amount actually available for penetration is significantly reduced by high permeant volatility. In contrast, application of N-nitrosodiethanolamine (NDELA) at a concentration of 1 microgram/microliter as an infinite dose generated an average total absorption over 48 hr of 23.6 +/- 6.4%, representing a total flux of 103.9 +/- 28.4 micrograms/cm2. In the case of NDELA, no evaporative loss was evident.
K R Brain, and
K A Walters, and
V J James, and
W E Dressler, and
D Howes, and
C K Kelling, and
S J Moloney, and
S D Gettings
August 1993,
Fundamental and applied toxicology : official journal of the Society of Toxicology,
K R Brain, and
K A Walters, and
V J James, and
W E Dressler, and
D Howes, and
C K Kelling, and
S J Moloney, and
S D Gettings
May 2003,
Die Pharmazie,
K R Brain, and
K A Walters, and
V J James, and
W E Dressler, and
D Howes, and
C K Kelling, and
S J Moloney, and
S D Gettings
February 1981,
The Journal of investigative dermatology,
K R Brain, and
K A Walters, and
V J James, and
W E Dressler, and
D Howes, and
C K Kelling, and
S J Moloney, and
S D Gettings
July 1997,
Occupational and environmental medicine,
K R Brain, and
K A Walters, and
V J James, and
W E Dressler, and
D Howes, and
C K Kelling, and
S J Moloney, and
S D Gettings
April 2002,
International journal of pharmaceutics,
K R Brain, and
K A Walters, and
V J James, and
W E Dressler, and
D Howes, and
C K Kelling, and
S J Moloney, and
S D Gettings
March 2022,
The Journal of dermatological treatment,
K R Brain, and
K A Walters, and
V J James, and
W E Dressler, and
D Howes, and
C K Kelling, and
S J Moloney, and
S D Gettings
March 2004,
Toxicology,
K R Brain, and
K A Walters, and
V J James, and
W E Dressler, and
D Howes, and
C K Kelling, and
S J Moloney, and
S D Gettings
January 2004,
Die Pharmazie,
K R Brain, and
K A Walters, and
V J James, and
W E Dressler, and
D Howes, and
C K Kelling, and
S J Moloney, and
S D Gettings
January 2008,
PDA journal of pharmaceutical science and technology,
K R Brain, and
K A Walters, and
V J James, and
W E Dressler, and
D Howes, and
C K Kelling, and
S J Moloney, and
S D Gettings
March 2015,
Cutaneous and ocular toxicology,
